Phenotype and Multi-omics Analysis of Children With Congenital Diarrhea and Enteropathy in China
A Case-control Study of Phenotype and Multi-omics Analysis of Children With Congenital Diarrhea and Enteropathy in China
1 other identifier
observational
60
1 country
1
Brief Summary
This study will establish a clinical cohort of children with congenital diarrhea and enteropathy (CODE), mine biomarkers of CODE through multi-omics technology and construct a clinical risk prediction model.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2024
CompletedFirst Posted
Study publicly available on registry
April 10, 2024
CompletedStudy Start
First participant enrolled
April 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
ExpectedSeptember 10, 2025
September 1, 2025
2 years
March 21, 2024
September 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical phenotype of congenital diarrhea and enteropathy in China
Describe the clinical phenotype(Birth status, family history, clinical features of diarrhea, laboratory examination, endoscopic and histological evaluation results, growth and development indicators, previous treatment and effect were collected) of congenital diarrhea and enteropathy in China,We will use our own mobile application or to collect the relevant data, which will be filled in by the parents of the child.
Within approximately 2 years of enrollment
Secondary Outcomes (2)
Biomarkers of congenital diarrhea and enteropathy with diagnostic value through microbiome, metabolome and proteome features
Within approximately 2 years of enrollment
Cinical risk prediction model for congenital diarrhea and enteropathy built by artificial intelligence and machine learning
Within approximately 30 months of enrollment
Study Arms (2)
Case
Congenital diarrhea and enteropathy (CODE) patients
Control
Healthy children
Eligibility Criteria
Patients with chronic diarrhea lasting greater than 2 months or greater than 1 month in patients younger than 2 months of age
You may qualify if:
- Patients with chronic diarrhea lasting greater than 2 months or greater than 1 month in patients younger than 2 months of age
- Patients with consent from parents or legal guardians
You may not qualify if:
- Chronic diarrhea caused by specific infections, i.e. CMV, Clostridioides difficile
- Chronic diarrhea with necrotizing enterocolitis, short bowel syndrome
- Functional diarrhea
- Patients with poor compliance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yanqiu Wang
Shanghai, Shanghai Municipality, 201102, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2024
First Posted
April 10, 2024
Study Start
April 15, 2024
Primary Completion
April 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
September 10, 2025
Record last verified: 2025-09